The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin therapy is unlikely to prevent cyclic strokes and may raise the risk of liberal and death in work with subcortical stroke gospel to late-breaking quest presented at the stars and stripes stars and stripes Stroke Association's International Stroke colloquy 2012. Because of these unpolished


copyrights:cite this source roget's ii: the new lexicon



if (lexico_globals.googleafc.ads.content.length)
{
document.write(lexico_globals.googleafc.ads.contenttop);
document.write(lexico_globals.googleafc.ads.sponsoredlinks);
document.write(lexico_globals.googleafc.ads.content[2]);
document.write("") results, researchers ended the anti-clotting part of the Secondary obstruction of Small Subcortical Strokes Trial (SPS3) in August 2011. The part of the study that examines the effect of high blood confining treatments will continue...

More: - The rest...